Atlas Trials

Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

Clinical trial NCT00006232 · COMPLETED

Trial details

NCT number
NCT00006232
Sponsor
West of Scotland Lymphoma Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
1996-10-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.